Paju A - Search Results

1

Increased expression of tumor-associated trypsin inhibitor, TATI, in prostate cancer and in androgen-independent 22Rv1 cells.

Paju A, Hotakainen K, Cao Y, Laurila T, Gadaleanu V, Hemminki A, Stenman UH, Bjartell A. Paju A, et al. Eur Urol. 2007 Dec;52(6):1670-9. doi: 10.1016/j.eururo.2007.01.096. Epub 2007 Feb 5. Eur Urol. 2007. PMID: 17306443

2

Chorionic gonadotropin beta-subunit and core fragment in bladder cancer: mRNA and protein expression in urine, serum and tissue.

Hotakainen K, Haglund C, Paju A, Nordling S, Alfthan H, Rintala E, Stenman UH. Hotakainen K, et al. Among authors: paju a. Eur Urol. 2002 Jun;41(6):677-85. doi: 10.1016/s0302-2838(02)00125-2. Eur Urol. 2002. PMID: 12074787

3

Biochemistry and clinical role of trypsinogens and pancreatic secretory trypsin inhibitor.

Paju A, Stenman UH. Paju A, et al. Crit Rev Clin Lab Sci. 2006;43(2):103-42. doi: 10.1080/10408360500523852. Crit Rev Clin Lab Sci. 2006. PMID: 16517420 Review.

4

Tumor associated trypsin inhibitor as a prognostic factor in renal cell carcinoma.

Paju A, Jacobsen J, Rasmuson T, Stenman UH, Ljungberg B. Paju A, et al. J Urol. 2001 Mar;165(3):959-62. J Urol. 2001. PMID: 11176522

5

Differential expression of trypsinogen and tumor-associated trypsin inhibitor (TATI) in bladder cancer.

Hotakainen K, Bjartell A, Sankila A, Järvinen R, Paju A, Rintala E, Haglund C, Stenman UH. Hotakainen K, et al. Among authors: paju a. Int J Oncol. 2006 Jan;28(1):95-101. doi: 10.3892/ijo.28.1.95. Int J Oncol. 2006. PMID: 16327984

6

Prostate-specific antigen and other prostate-derived proteases cleave IGFBP-3, but prostate cancer is not associated with proteolytically cleaved circulating IGFBP-3.

Koistinen H, Paju A, Koistinen R, Finne P, Lövgren J, Wu P, Seppälä M, Stenman UH. Koistinen H, et al. Among authors: paju a. Prostate. 2002 Feb 1;50(2):112-8. doi: 10.1002/pros.10039. Prostate. 2002. PMID: 11816019

7

Expression of the free beta-subunit of human chorionic gonadotropin in renal cell carcinoma: prognostic study on tissue and serum.

Hotakainen K, Ljungberg B, Haglund C, Nordling S, Paju A, Stenman UH. Hotakainen K, et al. Among authors: paju a. Int J Cancer. 2003 May 1;104(5):631-5. doi: 10.1002/ijc.11000. Int J Cancer. 2003. PMID: 12594819

8

Expression of trypsinogen-1, trypsinogen-2, and tumor-associated trypsin inhibitor in ovarian cancer: prognostic study on tissue and serum.

Paju A, Vartiainen J, Haglund C, Itkonen O, von Boguslawski K, Leminen A, Wahlström T, Stenman UH. Paju A, et al. Clin Cancer Res. 2004 Jul 15;10(14):4761-8. doi: 10.1158/1078-0432.CCR-0204-03. Clin Cancer Res. 2004. PMID: 15269150

9

Expression of tumor-associated trypsinogens (TAT-1 and TAT-2) in prostate cancer.

Bjartell A, Paju A, Zhang WM, Gadaleanu V, Hansson J, Landberg G, Stenman UH. Bjartell A, et al. Among authors: paju a. Prostate. 2005 Jun 15;64(1):29-39. doi: 10.1002/pros.20236. Prostate. 2005. PMID: 15651064

10

Mutations N34S and P55S of the SPINK1 gene in patients with chronic pancreatitis or pancreatic cancer and in healthy subjects: a report from Finland.

Lempinen M, Paju A, Kemppainen E, Smura T, Kylänpää ML, Nevanlinna H, Stenman J, Stenman UH. Lempinen M, et al. Among authors: paju a. Scand J Gastroenterol. 2005 Feb;40(2):225-30. doi: 10.1080/00365520510011560. Scand J Gastroenterol. 2005. PMID: 15764155

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

32 results

Search Page

Filters